CellaVision AB
OTC:CLVSF

Watchlist Manager
CellaVision AB Logo
CellaVision AB
OTC:CLVSF
Watchlist
Price: 20.24 USD Market Closed
Updated: May 19, 2024

Operating Margin
CellaVision AB

25.5%
Current
26%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
25.5%
=
Operating Profit
180.8m
/
Revenue
708.3m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
SE
CellaVision AB
STO:CEVI
5.6B SEK
26%
US
Abbott Laboratories
NYSE:ABT
181.1B USD
16%
US
Intuitive Surgical Inc
NASDAQ:ISRG
141.5B USD
25%
US
Stryker Corp
NYSE:SYK
127.5B USD
21%
IE
Medtronic PLC
NYSE:MDT
114.2B USD
20%
US
Boston Scientific Corp
NYSE:BSX
109.7B USD
17%
US
Becton Dickinson and Co
NYSE:BDX
68.6B USD
11%
DE
Siemens Healthineers AG
XETRA:SHL
59.2B EUR
12%
US
Edwards Lifesciences Corp
NYSE:EW
53.7B USD
29%
US
Dexcom Inc
NASDAQ:DXCM
52B USD
17%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
373.7B CNY
35%
CellaVision AB
STO:CEVI
Country SE
Market Cap 5.6B SEK
Operating Margin
26%
Abbott Laboratories
NYSE:ABT
Country US
Market Cap 181.1B USD
Operating Margin
16%
Intuitive Surgical Inc
NASDAQ:ISRG
Country US
Market Cap 141.5B USD
Operating Margin
25%
Stryker Corp
NYSE:SYK
Country US
Market Cap 127.5B USD
Operating Margin
21%
Medtronic PLC
NYSE:MDT
Country IE
Market Cap 114.2B USD
Operating Margin
20%
Boston Scientific Corp
NYSE:BSX
Country US
Market Cap 109.7B USD
Operating Margin
17%
Becton Dickinson and Co
NYSE:BDX
Country US
Market Cap 68.6B USD
Operating Margin
11%
Siemens Healthineers AG
XETRA:SHL
Country DE
Market Cap 59.2B EUR
Operating Margin
12%
Edwards Lifesciences Corp
NYSE:EW
Country US
Market Cap 53.7B USD
Operating Margin
29%
Dexcom Inc
NASDAQ:DXCM
Country US
Market Cap 52B USD
Operating Margin
17%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Country CN
Market Cap 373.7B CNY
Operating Margin
35%

Profitability Report

View the profitability report to see the full profitability analysis for CellaVision AB.

Full Profitability Report

See Also

Summary
CLVSF intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLVSF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLVSF stock valuation using valuation multiples.
Wall Street Estimates
CLVSF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLVSF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
25.5%
=
Operating Profit
180.8m
/
Revenue
708.3m
What is the Operating Margin of CellaVision AB?

Based on CellaVision AB's most recent financial statements, the company has Operating Margin of 25.5%.

ALPHA SPREAD
Join more than 138,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.